West Pharmaceutical Services Profit Margin

West Pharmaceutical Services (WST) currently reports a profit margin of 16.98% as of June 2026. That compares with 16.48% in the prior-year period — up 3.1% year over year. That is above the Healthcare sector average of 13.89%. Use the charts on this page to explore West Pharmaceutical Services's profit margin history and peer comparisons.

West Pharmaceutical Services's profit margin increased from 16.48% to 16.98% — a 3.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

West Pharmaceutical Services's profit margin of 16.98% is higher than the Healthcare sector average of 13.89%. That is roughly 22.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but West Pharmaceutical Services's current 16.98% should be judged against Healthcare norms (sector average: 13.89%) and against WST's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 16.98%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for West Pharmaceutical Services, and consider following WST for alerts when major investors trade the stock.